Sulfamethoxazole: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Sulfamethoxazole }} | ||
'''''For patient information, click <u>[[ | '''''For patient information, click <u>[[Sulfamethoxazole (patient information)|here]]'''''</u>. | ||
{{CMG}}; {{AE}} {{MM}} | {{CMG}}; {{AE}} {{MM}} | ||
==Overview== | ==Overview== | ||
''' | '''Sulfamethoxazole''' is a [[Sulfonamide (medicine)|sulfonamide]] [[bacteriostatic]] [[antibiotic]]. It is most often used as part of a synergistic combination with [[trimethoprim]] in a 5:1 ratio in [[co-trimoxazole]], which is also known as [[Bactrim]], [[Septrin]], or Septra (also abbreviated SMX/TMP). Its primary activity is against susceptible forms of ''[[Streptococcus]]'', ''[[Staphylococcus aureus]]'', ''[[Escherichia coli]]'', ''[[Haemophilus influenzae]]'', and [[oral]] [[anaerobes]]. It is commonly used to treat urinary tract infections. In addition can be used as an alternative to [[amoxicillin]]-based antibiotics to treat [[sinusitis]]. | ||
==Category== | ==Category== | ||
Line 11: | Line 11: | ||
==US Brand Names== | ==US Brand Names== | ||
BACTRIM DS''''''<sup>®</sup> | |||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[ | ''' [[Sulfamethoxazole description|Description]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole indications and usage|Indications and Usage]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole contraindications|Contraindications]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole adverse reactions|Adverse Reactions]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole dosage and administration|Dosage and Administration]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole how supplied|How Supplied]]''' | ||
'''| [[ | '''| [[Sulfamethoxazole labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
The systemic sulfonamides are bacteriostatic agents having a similar spectrum of activity. Sulfonamides competitively inhibit bacterial synthesis of folic acid (pteroylglutamic acid) from aminobenzoic acid. Resistant strains are capable of utilizing folic acid precursors or preformed folic acid.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = | The systemic sulfonamides are bacteriostatic agents having a similar spectrum of activity. Sulfonamides competitively inhibit bacterial synthesis of folic acid (pteroylglutamic acid) from aminobenzoic acid. Resistant strains are capable of utilizing folic acid precursors or preformed folic acid.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = Sulfamethoxazole TABLET [EON LABS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10549cba-9c15-4d2e-a68c-5afbc178591d | publisher = | date = | accessdate}}</ref> | ||
==References== | ==References== | ||
Line 33: | Line 33: | ||
[[Category:Antibiotics]] | [[Category:Antibiotics]] | ||
[[Category:Wikinfect]] | [[Category:Wikinfect]] | ||
Revision as of 01:22, 10 January 2014
For patient information, click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Sulfamethoxazole is a sulfonamide bacteriostatic antibiotic. It is most often used as part of a synergistic combination with trimethoprim in a 5:1 ratio in co-trimoxazole, which is also known as Bactrim, Septrin, or Septra (also abbreviated SMX/TMP). Its primary activity is against susceptible forms of Streptococcus, Staphylococcus aureus, Escherichia coli, Haemophilus influenzae, and oral anaerobes. It is commonly used to treat urinary tract infections. In addition can be used as an alternative to amoxicillin-based antibiotics to treat sinusitis.
Category
US Brand Names
BACTRIM DS'®
FDA Package Insert
Description | Clinical Pharmacology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied | Labels and Packages
Mechanism of Action
The systemic sulfonamides are bacteriostatic agents having a similar spectrum of activity. Sulfonamides competitively inhibit bacterial synthesis of folic acid (pteroylglutamic acid) from aminobenzoic acid. Resistant strains are capable of utilizing folic acid precursors or preformed folic acid.[1]
References
- ↑ "Sulfamethoxazole TABLET [EON LABS, INC.]". Text " accessdate" ignored (help)